Genetically predicted enrichment of Peptostreptococcaceae is causally associated with a lower risk of hypertensive heart disease.
Do genetically determined gut microbiota features causally influence the risk of heart failure and its subtypes?
Genetically predicted enrichment of the gut microbial family Peptostreptococcaceae is causally associated with a lower risk of hypertensive heart disease, highlighting a potential microbiome-based therapeutic target.
Effect estimate: OR 0.355 (95% CI 0.193–0.656)
p-value: p=<0.001
Background: Gut microbiota are associated with heart failure (HF); however, the causal relationship between gut microbial communities and HF of varying etiologies remains incompletely established. Methods: This study leveraged two-sample Mendelian randomization (MR) to investigate whether genetically determined gut microbiota features causally influence HF and its related subtypes. Instrumental variables (IVs) for gut microbiota were derived from a large-scale, genome-wide association study (GWAS) of microbial traits conducted by the MiBioGen consortium, which included 18,340 individuals. Summary statistics for HF and its subtypes were extracted from the FinnGen Release 7, encompassing 19,350 all-cause HF cases and 288,996 controls. The Wald ratio and inverse-variance weighted analyses were applied to calculate the causal estimates. Results: A total of 19 single-nucleotide polymorphisms (SNPs) corresponding to 18 gut microbial taxa were selected as IVs. A significant inverse causal association was identified between the family Peptostreptococcaceae and the risk of hypertensive heart disease (odds ratio (OR): 0.355, 95% confidence interval (CI): 0.193–0.656; p < 0.001; q = 0.018). Several additional taxa showed suggestive causal associations with HF or its precursor conditions, although these did not survive multiple-testing correction. Conclusions: Genetically predicted enrichment of Peptostreptococcaceae is causally associated with a lower risk of hypertensive heart disease. These MR findings warrant a mechanistic dissection of Peptostreptococcaceae-mediated pathways as a potential therapeutic lever for the prevention and treatment of hypertension-mediated HF.
Xu et al. (Thu,) conducted a other in Heart Failure (n=19,350). Peptostreptococcaceae vs. no Peptostreptococcaceae was evaluated on Risk of hypertensive heart disease (OR 0.355, 95% CI 0.193–0.656, p=<0.001). Genetically predicted enrichment of Peptostreptococcaceae is causally associated with a lower risk of hypertensive heart disease.